Coronavirus impact: 20 July - positive news from a respiratory drug
20/07/2020 · Gamma Communications (GAMA) · MJ Hudson Group PLC (MJH) · Pittards (PTD) · Synairgen · Venture Life Group PLC (VLG)
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
Synairgen: shares soar of positive Covid-19 test results
Previous article Next article
DON'T MISS OUT!
Get top investment ideas to help safeguard and grow your wealth.
Invaluable insight from the exciting world of smaller companies.
REGISTER FREEDON'T MISS OUT ON OUR PREMIUM CONTENT
Become a champion investor for just £90 a year. Benefit from our high performing portfolios:
- Ultimate Stocks
- Income Boosters
- Mega Tends
- Bonkers Bargains
- Stonking Small Caps
- IHT qualifying selections
- ...and more
More on Gamma Communications
Stonking Small Caps: terrific results lift the shares
This fast-growing provider of unified communications is a fantastic company, generating attractive operating margins and heaps…
Whopping dividends from AIM
Updates covered here include several AIM and small cap companies offering high dividend payouts. While some…
More on MJ Hudson Group PLC
DUKE of hazard | Bonkers Bargain ahead again
Updates from AIM covered here includes news of the suspension of trading in the shares of a…
Coronavirus impact: 20 July - positive news from a respiratory drug
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Pittards
Coronavirus impact: 30 Sept - some big pandemic winners and losers
Boohoo Group announced another set of fantastic results and, with a huge pile of cash at…
Coronavirus impact: 20 July - positive news from a respiratory drug
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Synairgen
Not so wacky, but still unusual!
A new strategy appears to be delivering for an unusual business covered here. Elsewhere, a small…
Coronavirus impact: 20 July - positive news from a respiratory drug
Assessment of Synairgen’s drug in Covid-19 patients could signal a major breakthrough in the treatment patients.
More on Venture Life Group PLC
Knocking the lights out…again
One of AIM’s largest companies has issued another positive trading update sending the shares sharply higher…
Acquisition machines ‘mostly’ deliver
Results and updates covered here include those of several acquisition driven companies, which also managed to…